Play a few matches of The Finals to earn yourself a nifty new skin in Arc Raiders.
ARC-520 achieves significant HBV s-Antigen (HBsAg) reductions in humans, particularly in treatment naïve, HBeAg-positive patients In a cohort of NUC-naïve, HBeAg-positive patients, best peak HBsAg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback